New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
09:20 EDTKTOS, PAY, HDY, EXXI, MX, PRMW, EPL, FCEL, RAD, EXPR, SNTA, QIWI, GERN, OXGNOn The Fly: Pre-market Movers
UP AFTER EARNINGS: VeriFone (PAY), up 8.5%... Primo Water (PRMW), up 8.3%... QIWI (QIWI), up 2.5%. ALSO HIGHER: Oxigene (OXGN), up 128% following results from its Phase 2 clinical trial evaluating Avastin with or without ZYBRESTAT to treat patients with recurrent ovarian cancer... Rite Aid (RAD), up 3% following upgrade at Goldman... EPL Oil & Gas (EPL), up 28.8% after Energy XXI (EXXI) to acquire the company for $2.3B. DOWN AFTER EARNINGS: Express (EXPR), down 13%... Kratos Defense (KTOS), down 10%. ALSO LOWER: Hyperdynamics (HDY), down 59% after U.S. Department of Justice and the SEC to open investigations into the activities of the company... Geron (GERN), down 61% after announcing IND clinical hold affecting trials of imetelstat... Synta Pharmaceuticals (SNTA), down 16.7% after downgraded at Stifel, BMO Capital... FuelCell (FCEL), down 3.6% following downgrade at Cowen... MagnaChip (MX), down 10.7% after announcing it will restate prior financial statements... Northwest Biotherapeutics (NWBO), down 6.8% following downgrade at Oppenheimer.
News For EXPR;OXGN;QIWI;RAD;GERN;SNTA;FCEL;EPL;EXXI;PAY;PRMW;HDY;KTOS;MX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
12:26 EDTRADOptions with increasing implied volatility
Subscribe for More Information
February 4, 2016
11:21 EDTPAYOptions with increasing call volume; FMC HST XME RIO BHP PAY DNDK BSX ALLY SWFT
09:16 EDTRADRite Aid shareholders approve merger with Walgreens Boots Alliance
Subscribe for More Information
February 3, 2016
14:13 EDTRADRite Aid to host special shareholder meeting
Subscribe for More Information
11:03 EDTRADOptions with increasing implied volatility: LC RAD CIEN ADSK BWLD
Subscribe for More Information
10:00 EDTQIWIOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AIG (AIG) downgraded to Market Perform from Outperform at William Blair... Credit Acceptance (CACC) downgraded to Underperform at Raymond James... CIT Group (CIT) downgraded to Neutral from Buy at Citi... Cobalt (CIE) downgraded at Stifel... Cypress Energy (CELP) downgraded to Outperform from Strong Buy at Raymond James... Freeport McMoRan (FCX) downgraded on weak near-term outlook at Argus... Gastar Exploration (GST) downgraded to In-Line from Outperform at Imperial Capital... Intersil (ISIL) downgraded to Sell from Neutral at Citi... LyondellBasell (LYB) downgraded to Outperform from Top Pick at RBC Capital... Marriott (MAR) downgraded to Market Perform from Outperform at Wells Fargo... Microchip (MCHP) downgraded to Sell from Neutral at Goldman... Morgan Stanley (MS) downgraded to Underweight from Neutral at Atlantic Equities... Navios Maritime Partners (NMM) downgraded to Hold from Buy at Deutsche Bank... Peapack-Gladstone (PGC) downgraded to Hold from Buy at Sandler O'Neill... QIWI (QIWI) downgraded to Market Perform from Outperform at William Blair... STORE Capital (STOR) downgraded to Neutral from Buy at Ladenburg... Spark Energy (SPKE) downgraded to Neutral from Outperform at Baird... Stone Energy (SGY) downgraded to In-Line from Outperform at Imperial Capital... SunEdison Semiconductor (SEMI) downgraded to Sell from Neutral at Goldman... Teradyne (TER) downgraded to Neutral from Buy at Goldman... Texas Instruments (TXN) downgraded to Sell from Neutral at Goldman... UBS (UBS) downgraded to Sector Perform from Outperform at RBC Capital... Whiting Petroleum (WLL) downgraded on oil price outlook at Stifel... Xcel Energy (XEL) downgraded to Sell from Neutral at UBS... Xilinx (XLNX) downgraded to Buy from Conviction Buy at Goldman... Yahoo (YHOO) downgraded to Hold from Buy at Axiom.
09:05 EDTQIWIQIWI downgraded to Market Perform from Outperform at William Blair
William Blair analyst Robert Napoli downgraded QIWI to Market Perform after the company cut its FY15 outlook given the deteriorating macro environment in Russia.
09:05 EDTOXGNOXiGENE announces FDA approval of protocol for FOCUS phase 2/3 study of CA4P
OXiGENE announced that the FDA has approved the protocol for FOCUS, OXiGENE's phase 2/3 study of CA4P for the treatment of platinum-resistant ovarian cancer. FOCUS will test whether CA4P, the company's lead investigational drug, improves progression-free survival when combined with bevacizumab and chemotherapy. If the trial is successful, data from FOCUS would be used as the basis for a new drug application to the FDA.
06:35 EDTQIWIQIWI cuts FY15 adjusted revenue view to up 15%-16% vs. FY14
QIWI announced downward revisions to its previously announced full-year 2015 Adjusted Net Revenue guidance to a range of a 15% to 16% increase over 2014, down from its previous guidance of an 18% to 22% increase over 2014. In addition, QIWI is revising its previously announced full-year 2015 Adjusted Net Profit guidance to a range of a 16% to 18% increase over 2014, down from its previous guidance of an 18% to 22% increase over 2014.The downward revision in the Company's Adjusted Net Revenue guidance is primarily due to the continued economic recession in Russia as well as weak consumer demand pressured by high inflation and decreasing real income, which has resulted in performance that was lower than anticipated across certain market verticals, in particular e-commerce and money remittance. In the e-commerce market vertical, the Company expected to see a seasonal increase in demand from customers in accordance with trends observed in previous years that failed to materialize, particularly in physical e-commerce. In addition, the money remittance market vertical underperformed in terms of volumes as well as net revenue due to shifting migration trends and the termination of a few partnerships with counterparties and agents.The downward revision in the Company's Adjusted Net Profit guidance is primarily caused by the downward revision in the Company's Adjusted Net Revenue guidance and a substantial increase in bad debt expense compared to the full year ended December 31, 2014, resulting from an increase in reserves for receivables from several of QIWI's agents who have shown signs of financial instability.
February 2, 2016
11:50 EDTEXXIOptions with increasing put volume; BKLN AKS ROK MCHP EXXI TPX ALU TXT RCL
Subscribe for More Information
10:39 EDTRADOptions with increasing implied volatility: LC RAD CIEN
09:56 EDTRADRite Aid's RediClinic, Aria Health announce alliance
Subscribe for More Information
February 1, 2016
10:25 EDTRADWilliaOptions with increasing implied volatility: WMB ENDP RAD
Subscribe for More Information
January 29, 2016
10:16 EDTRADOptions with increasing implied volatility: WMB W CERS RAD CRM GILD MNST
Subscribe for More Information
January 28, 2016
10:32 EDTRADOptions with increasing implied volatility: RAD GMCR
08:32 EDTRADRite Aid reports January SSS down 1.4%
For the four weeks ended Jan. 23, 2016, same store sales decreased 1.4% over the prior-year period. January front-end same store sales decreased 1.9%. Pharmacy same store sales, which included an approximate 242 basis points negative impact from new generic introductions, decreased 1.2%. Prescription count at comparable stores decreased 1% over the prior-year period. Total drugstore sales for the four-week period decreased 1.3% with sales of $2B compared to $2.026B for the same period last year. Prescription sales accounted for 70.5% of drugstore sales, and third party prescription sales represented 97.7% of pharmacy sales.
January 26, 2016
10:32 EDTRADOptions with increasing implied volatility: CLDX SNDK GMCR RAD
Subscribe for More Information
January 25, 2016
06:06 EDTMXMagnaChip surpasses 160M mark in AMOLED driver IC units shipped
MagnaChip Semiconductor announced that its cumulative shipment of AMOLED display driver ICs has surpassed 160 million units since initial shipments began in 2007. MagnaChip is supplying AMOLED display driver ICs to global smartphone, tablet PC and digital still camera manufacturers through direct and indirect channels and is now targeting the head-mounted display application for the Virtual Reality market. MagnaChip is also targeting applications in automotive displays and infotainment.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use